Regular expression of osteopontin in granular cell tumor: distinctive feature among Schwannian cell tumors.
For further characterization of S-100 protein-positive granular cell tumor (GCT), the expression of osteopontin (OPN) in the tumor cells was compared with other types of Schwannian cell tumors. Twenty GCT, three amputation neuromas, 12 neurilemmomas (NM) and three malignant peripheral nerve sheath tumors (MPNST) were used. In addition, two granular cell epulides were employed because of histological similarity to that of GCT. Immunohistochemistry by anti-OPN-monoclonal antibody revealed OPN-immunoreactivity in tumor cells of all GCT and stromal macrophages in neurilemmomas and one MPNST, but neither in amputation neuromas nor in granular cell epulides. All nine GCT studied by in situ hybridization (ISH) and all three GCT analyzed by reverse transcription-polymerase chain reaction (RT-PCR) were positive for OPN mRNA. In contrast, seven NM and three amputation neuromas were negative for OPN mRNA by either ISH or RT-PCR, while macrophages infiltrated in these tumors had OPN mRNA consistently. Double immunostaining for OPN and CD68, a lysosome-associated glycoprotein, showed their colocalization in tumor cells of GCT, suggesting a possible degradation of OPN by lysosomes. In conclusion, GCT among Schwannian cell tumors consistently express OPN, but its biological significance requires further investigation.
Hoshi
Nobuo
N
Department of Pathology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Sugino
Takashi
T
Suzuki
Toshimitsu
T
D015703:Antigens, CD / Q000032:analysis; D015214:Antigens, Differentiation, Myelomonocytic / Q000032:analysis; D015972:Gene Expression Regulation, Neoplastic; D016586:Granular Cell Tumor / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D018317:Nerve Sheath Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D009442:Neurilemmoma / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D009463:Neuroma / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D053495:Osteopontin; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D009418:S100 Proteins / Q000032:analysis; D012583:Schwann Cells / Q000737:chemistry / Q000378:metabolism / Q000473:pathology*; D012795:Sialoglycoproteins / Q000096:biosynthesis / Q000235:genetics*; D000097382:CD68 Molecule
D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D053495:Osteopontin; D012333:RNA, Messenger; D009418:S100 Proteins; D012795:Sialoglycoproteins; C067980:CD68 antigen, human; D000097382:CD68 Molecule; C506895:SPP1 protein, human